Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

Prediction of Creatinine Clearance from Serum Creatinine

1976 • 15,066 citations

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1982 • 10,605 citations

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

1989 • 1,831 citations

Taxol: A Novel Investigational Antimicrotubule Agent

1990 • 1,084 citations

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

1988 • 704 citations

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

1993 • 441 citations

Sequences of taxol and cisplatin: a phase I and pharmacologic study.

1991 • 438 citations

Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines

1993 • 402 citations

Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules

1981 • 367 citations

Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results

1993 • 346 citations

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.

1989 • 325 citations

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.

1986 • 325 citations

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

1990 • 250 citations

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

1994 • 221 citations

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.

1993 • 193 citations

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.

1993 • 155 citations

Prognostic implications of the International Staging System for Lung Cancer.

1988 • 132 citations

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.

1994 • 132 citations

Cisplatin-Cyclophosphamide-Mitomycin Combination Chemotherapy With Supportive Care Versus Supportive Care Alone for Treatment of Metastatic Non-Small-Cell Lung Cancer

1993 • 130 citations

Paclitaxel administered by 1-hour infusion. Preliminary results of a phase 1/11 trial comparing two schedules

1994 • 55 citations

Randomized Trial of Two Doses of Taxol in Metastatic Breast Cancer: An Interim Analysis

1994 • 43 citations

Measurement of glomerular filtration rate in homozygous sickle cell disease: a comparison of 51Cr-EDTA clearance, creatinine clearance, serum creatinine and beta 2 microglobulin.

1990 • 24 citations

Phase II study with paclitaxel in advanced inoperable non-small cell lung cancer (NSCLC)—The European experience

1994 • 10 citations